RFK Jr. Eases Access to Unproven Peptides Despite Opposition From FDA Scientists
(MedPage Today) -- The Trump administration on Wednesday acted to ease access to unproven peptide drugs favored by Health Secretary Robert F. Kennedy Jr., and FDA scientific staffers had little input on the decision and opposed the changes, according...
We haven't written up this one. MedPage Today has the full story — the link below goes straight to it.